Recent Updates — CNC
Centene Corporation reported third-quarter results with total revenues of $50.6 billion and an adjusted diluted earnings per share of $0.58, compared to a GAAP loss of $(0.14) per share. The company increased its 2026 full-year adjusted diluted EPS guidance floor to greater than $5.20, up from previous estimates, while lowering the Health Benefits Ratio (HBR) mid-point expectation by 15 basis points to 90.75%. Centene also reduced total debt by $1.1 billion since June 30, including the full redemption of its 2027 Senior Notes in October. The company operates as a managed care organization providing healthcare coverage and services primarily to government-sponsored programs like Medicaid and Medicare.
On October 8, 2026, Centene Corporation delivered a notice of redemption for all outstanding 4.25% Notes due December 15, 2027, with an aggregate principal amount of $568,664,000. The notes are scheduled to be redeemed on October 23, 2026, at a price equal to 100% of the principal amount plus accrued and unpaid interest. Following this redemption, no 2027 Notes will remain outstanding. Centene Corporation operates in the managed healthcare industry.
Centene Corporation reaffirmed its full year 2026 financial guidance during participation in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026. The company maintained its GAAP diluted earnings per share (EPS) guidance of greater than $3.11 and its adjusted diluted EPS guidance of greater than $4.80. This update was provided to investors through a live audio webcast and subsequent discussions continuing through the week of September 21, 2026. Centene Corporation operates in the managed healthcare industry, providing health insurance and related services.
Centene Corporation announced that Chief Financial Officer Andrew Asher will step down on December 31, 2026, retiring from the company at the end of 2027 while serving as Strategic Advisor through year-end. Christopher Neczypor has been appointed as his successor, effective January 1, 2027. Neczypor previously served as CFO of Lincoln National Corporation and will join Centene in September 2026 as Executive Vice President. His compensation package includes a $1.1 million base salary, a target bonus of up to 200% of base, $5.25 million in annual long-term equity incentives, a $10 million one-time restricted stock unit grant for forfeited compensation, and a $2 million cash sign-on bonus. The company also reaffirmed its full-year 2026 adjusted diluted earnings per share guidance of greater than $4.80. Centene Corporation operates in the managed care industry, providing government-sponsored and commercial healthcare programs.
On July 29, 2026, Centene Corporation delivered a notice to partially redeem $500 million of its outstanding 4.25% Notes due December 15, 2027. The redemption is scheduled for August 13, 2026, at a price equal to 100% of the principal amount plus accrued and unpaid interest. Following this transaction, approximately $568.7 million of the notes will remain outstanding. Centene Corporation operates in the managed healthcare industry, providing health insurance and related services.
Centene Corporation reported second quarter 2026 financial results with total revenues of $53.6 billion and GAAP diluted earnings per share of $2.19. The company increased its full-year 2026 GAAP diluted EPS guidance to greater than $3.11 and adjusted diluted EPS guidance to greater than $4.80, citing underlying business strength and approximately $0.50 of non-recurring items. Centene also announced that Director Kenneth Burdick retired from the Board effective July 28, 2026, and Paul Diaz was elected to fill the vacancy. Centene operates in the managed healthcare industry, providing government-sponsored and commercial healthcare programs to under-insured individuals.